Accessibility: Skip TopNav
100% of Patients On IMX-110 Completed Planned Treatment Cycles
Immix Biopharma, Inc. (NASDAQ:IMMX)
Format
PNG
Source
Immix Biopharma, Inc.
Downloads
Original
Large
Medium
Small